The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
Abstract CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independ...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Portfolio
2021-05-01
|
| Sarja: | npj Breast Cancer |
| Linkit: | https://doi.org/10.1038/s41523-021-00256-2 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|